Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

01.05.12	Pfizer Inc. Issues Statement Regarding Pending Court Case (Businesswire)
26.04.12	Pfizer Hosts Annual Meeting Of Shareholders (Businesswire)
25.04.12	The Advil® Congestion Relief Project Visits St. Louis To Expand Building Space For More Access To Local Family Social Service Program (Businesswire)
23.04.12	Pfizer To Divest Nutrition Business To Nestlé (Businesswire)
19.04.12	Pfizer Invites Public To Listen To Webcast Of April 26 Annual Meeting Of Shareholders (Businesswire)
18.04.12	The Advil® Congestion Relief Project Visits Dayton To Relieve Community Center Congestion Allowing More Students To Participate In Local Mentorship Program (Businesswire)
11.04.12	The Advil® Congestion Relief Project Relieves Transportation Congestion in Albany to Help Get Students to Afterschool Programs (Businesswire)
09.04.12	"MasterChef” Judge Joe Bastianich Cooks With "Heart” At New Chicago Walgreens Flagship Store (Businesswire)
27.03.12	Pfizer Invites Public To View And Listen To Webcast Of May 1 Conference Call With Analysts (Businesswire)
26.03.12	Pfizer to Present New Data Highlighting Ongoing Research at 2012 Meeting of the American Association for Cancer Research (Businesswire)
13.03.12	Biocon And Pfizer Conclude Commercialization Agreement (Businesswire)
12.03.12	Pfizer’s Prevnar 13® Shown to be Immunogenic in Older Children and Adolescents (Businesswire)
06.03.12	Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference (Businesswire)
28.02.12	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
27.02.12	Pfizer Acquires Alacer Corp., a Leading Vitamin Supplements Company (Businesswire)
22.02.12	Pfizer Statement Regarding CDC’s ACIP Discussion of Prevnar 13® for Use in Adults (Businesswire)
17.02.12	Pfizer And Hisun Announce Progress On Potential Joint Venture To Increase Access To High Quality Branded Generic Medicines (Businesswire)
15.02.12	FDA Accepts Pfizer’s New Drug Application for Tafamidis Meglumine, a Novel, Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) (Businesswire)
01.02.12	Pfizer Issues Statement On Voluntary Recall (Businesswire)
31.01.12	Pfizer Reports Fourth-Quarter and Full-Year 2011 Results; Updates 2012 Financial Guidance (Businesswire)
27.01.12	U.S. Food And Drug Administration Approves Pfizer’s INLYTA® (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC) (Businesswire)
27.01.12	Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ Chronic Myeloid Leukemia (Businesswire)
26.01.12	Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer’s Care (Businesswire)
17.01.12	Medivation and Pfizer Announce Results from Phase 3 Concert Trial of Dimebon in Alzheimer’s Disease (Businesswire)
10.01.12	Introducing nutritionpossible.com – A New Resource That Offers Personalized Nutritional Guidance to Achieve Better Health (Businesswire)
03.01.12	Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference (Businesswire)
22.12.11	Pfizer Reports Results From Three Phase 4 Studies Demonstrating EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII Impact On Drug Liking And Withdrawal Symptoms (Businesswire)
20.12.11	Fort Myers Regional Partnership Announces Expansion of Chico’s FAS Corporate Headquarters (Businesswire)
20.12.11	Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts (Businesswire)
20.12.11	Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis (Businesswire)
16.12.11	Pfizer Reports Positive Results From Phase 3 Trial Of Lyrica (prebabalin) Capsules CV In Restless Legs Syndrome (Businesswire)
16.12.11	Molycorp Secures Government Approval To Conduct Heavy Rare Earth Exploratory Drilling (Businesswire)
16.12.11	Pfizer Broadens and Extends Commitment to Help Prevent Pneumococcal Disease in Infants and Young Children in the World’s Poorest Countries (Businesswire)
13.12.11	New Survey Reveals Top Misperceptions Parents Have When Treating Their Child’s Fever (Businesswire)
12.12.11	Pfizer Elects CEO Ian Read As Chairman Of The Board (Businesswire)
12.12.11	Pfizer Declares A 22-Cent First-Quarter 2012 Dividend (Businesswire)
09.12.11	Jon Bon Jovi Reveals His True Advil® Story (Businesswire)
08.12.11	The Advil® Congestion Relief Project Tackles Congestion in Chicago, the Country’s #1 City for Traffic Congestion* (Businesswire)
07.12.11	FDA Advisory Committee Finds The Benefit/Risk Profile Of Axitinib In Previously Treated Advanced Renal Cell Carcinoma (RCC) To Be Favorable (Businesswire)
05.12.11	Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients (Businesswire)
02.12.11	Pfizer Completes Acquisition of Excaliard (Businesswire)
01.12.11	Pfizer Completes Acquisition of Ferrosan Consumer Health’s Business (Businesswire)
22.11.11	Campbell Reports First-Quarter Results (Businesswire)
22.11.11	Pfizer to Acquire Excaliard Pharmaceuticals (Businesswire)
21.11.11	Pfizer And MIT Break Ground On New Research Units In Kendall Square (Businesswire)
21.11.11	Pfizer Announces European Medicines Agency Acceptance Of Regulatory Submission For Tofacitinib For The Treatment Of Rheumatoid Arthritis (Businesswire)
17.11.11	Pfizer’s Vyndaqel® (tafamidis) First Therapy Approved in the European Union for the Rare and Fatal Neurodegenerative Disease Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) (Businesswire)
16.11.11	The Advil® Congestion Relief Project Hits the Road to Relieve Congestion in Communities (Businesswire)
14.11.11	Kathryn Joosten Speaks Out About Lung Cancer Profiles; ‘Desperate’ to Share Her Personal Lung Cancer Story to Help Others (Businesswire)
13.11.11	New Data Presented On Phase 3 Trial Of ELIQUIS® (apixaban) In The Prevention Of Venous Thromboembolism In Patients With Acute Medical Illness (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

18:01		Starker Wochentag in New York: NASDAQ Composite liegt am Donnerstagmittag im Plus
18:01		Zuversicht in New York: S&P 500 mittags mit grünem Vorzeichen
18:01		NASDAQ 100 aktuell: NASDAQ 100 am Mittag mit positivem Vorzeichen
17:58		LSE-Handel FTSE 100 notiert letztendlich im Minus
17:58		Schwacher Handel in Zürich: SMI zum Handelsende in Rot
17:58		Donnerstagshandel in Zürich: SPI sackt zum Ende des Donnerstagshandels ab
17:55		Roche-Aktie gewinnt: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt
16:01		Freundlicher Handel: Dow Jones zum Handelsstart mit Zuschlägen

18:01

Starker Wochentag in New York: NASDAQ Composite liegt am Donnerstagmittag im Plus

18:01

Zuversicht in New York: S&P 500 mittags mit grünem Vorzeichen

18:01

NASDAQ 100 aktuell: NASDAQ 100 am Mittag mit positivem Vorzeichen

17:58

LSE-Handel FTSE 100 notiert letztendlich im Minus

17:58

Schwacher Handel in Zürich: SMI zum Handelsende in Rot

17:58

Donnerstagshandel in Zürich: SPI sackt zum Ende des Donnerstagshandels ab

17:55

Roche-Aktie gewinnt: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt

16:01

Freundlicher Handel: Dow Jones zum Handelsstart mit Zuschlägen

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nestle	74.20	0.13 %	K V
Swiss Life Hldg	689.40	0.06 %	K V
Kuehne+Nagel Int	202.30	0.00 %	K V
Swisscom	501.50	-0.30 %	K V
Swiss Re	129.10	-0.39 %	K V
Logitech Intl	73.02	-2.41 %	K V
Roche Hldg G	246.70	-3.25 %	K V
UBS Group	26.89	-3.34 %	K V
Part Grp Hldg	1’217.00	-4.29 %	K V
ABB	48.73	-5.42 %	K V

Nachrichten zu Pfizer Inc.

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten